Bottom line
FPHAX vs MEDX: the short answer
FPHAX (Pharmaceuticals Portfolio) and MEDX (Horizon Kinetics Medical ETF) are both mutual funds.
FPHAX is cheaper at 0.67% vs 0.85% — a difference of $18 a year per $10,000 invested.
Over five years, FPHAX returned +12.6% a year vs +5.8% for MEDX (reporting dates differ).
Updated Nov 19, 2026
FPHAX vs MEDX side by side
| FPHAX | MEDX | |
|---|---|---|
| Type | Mutual fund | ETF |
| Fund family | Fidelity | Roundhill |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 0.67% | 0.85% |
| Annual cost per $10k | $67 | $85 |
| 10-yr cost on $10k (prospectus) | $835 | $1,049 |
| Max front load | — | None |
| 12b-1 fee | 0% | 0% |
| 1-yr return | +30.3% | +28.4% |
| 5-yr return (annualized) | +12.6% | +5.8% |
| 10-yr return (annualized) | +10.0% | +5.7% |
| Best quarter | +18.5% | +15.0% |
| Worst quarter | −13.6% | −12.9% |
| Net assets (fund) | $1.5B | $19.1M |
| Number of holdings | 57 | 33 |
| Portfolio turnover | 77% | % |
| Returns as of | Apr 30, 2026 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | FPHAX | MEDX | Difference |
|---|---|---|---|
| 2025 | +30.3% | +28.4% | +1.8% |
| 2024 | +9.4% | −4.7% | +14.1% |
| 2023 | +12.5% | −6.0% | +18.6% |
| 2022 | +1.0% | +4.2% | −3.2% |
| 2021 | +11.8% | +10.6% | +1.2% |
| 2020 | +11.1% | +9.0% | +2.0% |
| 2019 | +31.6% | +16.0% | +15.6% |
| 2018 | +5.8% | +1.7% | +4.1% |
| 2017 | +10.7% | +10.7% | −0.0% |
| 2016 | −16.3% | −8.0% | −8.3% |
Source: Fund prospectus bar charts
Holdings overlap
7 of FPHAX's top 25 holdings also appear in MEDX's top 25.
| Holding | FPHAX | MEDX |
|---|---|---|
| ELI LILLY and CO | 28.78% | 18.46% |
| Gsk Plc | 8.17% | 2.71% |
| MERCK and CO INC | 4.74% | 3.96% |
| Astrazeneca Plc | 4.22% | 4.98% |
| JOHNSON and JOHNSON | 3.77% | 5.59% |
| Intellia Therapeutics Inc | 1.19% | 1.12% |
| Beam Therapeutics Inc | 1.10% | 1.51% |
Source: SEC Form N-PORT
FPHAX top 10
- ELI LILLY and CO — 28.78%
- Gsk Plc — 8.17%
- Viatris Inc — 5.45%
- Ucb Sa — 5.09%
- MERCK and CO INC — 4.74%
- Roche Holding Ag — 4.54%
- Legend Biotech Corp — 4.53%
- Astrazeneca Plc — 4.22%
- Elanco Animal Health Inc — 4.15%
- Jazz Pharmaceuticals Plc — 4.09%
MEDX top 10
- Eli Lilly & Co — 18.46%
- US Bank Mmda - Usbgfs 7 — 9.19%
- AbbVie Inc — 8.85%
- Novartis AG — 6.89%
- Johnson & Johnson — 5.59%
- Alkermes PLC — 5.53%
- AstraZeneca PLC — 4.98%
- Ionis Pharmaceuticals Inc — 4.53%
- Bristol-Myers Squibb Co — 4.42%
- Merck & Co Inc — 3.96%
FAQ
What is the difference between FPHAX and MEDX?
Which is cheaper, FPHAX or MEDX?
Should I own both FPHAX and MEDX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.